Suppr超能文献

CD40介导的c-Rel激活及c-myc RNA水平维持在减轻抗IgM诱导的生长停滞中的作用。

Role for CD40-mediated activation of c-Rel and maintenance of c-myc RNA levels in mitigating anti-IgM-induced growth arrest.

作者信息

Siebelt F, Berberich I, Shu G, Serfling E, Clark E A

机构信息

Department of Microbiology and Regional Primate Research Center, University of Washington, Seattle, Washington, 98195, USA.

出版信息

Cell Immunol. 1997 Oct 10;181(1):13-22. doi: 10.1006/cimm.1997.1198.

Abstract

CD40 crosslinking on B cells activates NF-kappaB and stress-activated protein kinase (SAPK) pathways. Since CD40 crosslinking rescues WEHI 231 B cells from anti-IgM-induced apoptosis, those pathways were likely candidates to be involved. Indeed, both signaling cascades predominated in anti-IgM-treated WEHI 231 cells, treated concurrently with anti-CD40 to rescue them from apoptosis. Crosslinking of CD40 activated the NF-kappaB proteins c-Rel and p50, but had no influence on their cytoplasmic steady state level. However, in contrast to-and even in the presence of-anti-IgM-mediated signals, engagement of CD40 resulted in a prolonged nuclear translocation of c-Rel, thereby allowing the formation of active NF-kappaB complexes. Consistent with this, the upstream regulatory element of the c-myc promoter, known to be regulated by NF-kappaB, was differently regulated after BCR ligation vs BCR plus CD40 crosslinking. The level of c-myc RNA was rapidly downregulated after BCR engagement, but persistent in the presence of CD40 signaling.

摘要

B细胞上的CD40交联激活核因子-κB(NF-κB)和应激激活蛋白激酶(SAPK)信号通路。由于CD40交联可使WEHI 231 B细胞免受抗IgM诱导的凋亡,因此这些信号通路可能参与其中。事实上,在抗IgM处理的WEHI 231细胞中,这两种信号级联均占主导地位,同时用抗CD40处理可使其免受凋亡。CD40交联激活了NF-κB蛋白c-Rel和p50,但对它们的细胞质稳态水平没有影响。然而,与抗IgM介导的信号相反,即使在存在抗IgM介导信号的情况下,CD40的激活也会导致c-Rel在细胞核内的转位延长,从而形成活性NF-κB复合物。与此一致的是,已知受NF-κB调控的c-myc启动子的上游调控元件,在BCR连接与BCR加CD40交联后受到不同的调控。BCR激活后,c-myc RNA水平迅速下调,但在存在CD40信号时持续存在。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验